Edition:
United Kingdom

People: Enzo Biochem Inc (ENZ.N)

ENZ.N on New York Stock Exchange

3.63USD
22 Apr 2019
Change (% chg)

$0.05 (+1.40%)
Prev Close
$3.58
Open
$3.58
Day's High
$3.69
Day's Low
$3.50
Volume
38,050
Avg. Vol
46,489
52-wk High
$6.88
52-wk Low
$2.33

Dey, Bruce 

Mr. Bruce A. Dey is Vice President - Sales and Marketing, Enzo Clinical Labs of the company. Prior to joining Enzo Clinical Labs, Mr. Dey served as Vice President, Sales & Marketing for CDS Laboratories from 1989 to 2001, which was acquired by Quest Diagnostics in November 2001. He began his career with SmithKline Beecham Clinical Laboratories. Mr. Dey earned a Bachelor of Science in Economics and a Master of Business Administration from The State University of New York at Albany.

Basic Compensation

Total Annual Compensation, USD 448,565
Restricted Stock Award, USD 8,840
Long-Term Incentive Plans, USD --
All Other, USD 39,091
Fiscal Year Total, USD 496,496

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Barry Weiner

1,246,880

Elazar Rabbani

1,476,670

James O'Brien

494,722

Bruce Dey

496,496

Dieter Schapfel

470,076

Gregory Bortz

197,500
As Of  31 Jul 2018